Aspirin and
nonsteroidal anti-inflammatory agents are known to induce gastroduodenal complications such as
ulcer,
bleeding, and
dyspepsia. In this study, we examined the prophylactic effect of
rebamipide, an anti-
ulcer agent with
free-radical scavenging and anti-inflammatory effect, on acidified
aspirin-induced gastric mucosal injury in rats. In addition, we investigated the mucosal barrier functions disrupted by
aspirin.
Oral administration of acidified
aspirin resulted in linear hemorrhagic erosions with increasing
myeloperoxidase activity and
thiobarbituric acid-reactive substance concentrations in the gastric mucosa.
Rebamipide suppressed these acidified
aspirin-induced gastric lesions and inflammatory changes significantly, and its protective effect was more potent in the case of repeated (twice daily for 3 days) treatment than single treatment before
aspirin administration. Immunostaining of zonula occludens (ZO)-1, one of the tight junctional
proteins, was strengthened in rat gastric mucosa after repeated administration of
rebamipide. In addition,
aspirin induced the increasing transport of fluorescine
isothiocyanate-labeled
dextrans with localized disruption and decreased expression of ZO-1
protein on rat gastric mucosal cell line RGM-1.
Rebamipide effectively prevented
aspirin-induced permeability changes and disruption of ZO-1 distribution. These results suggest that
rebamipide protects against
aspirin-induced gastric mucosal lesions by preserving gastric epithelial cell-to cell integrity in addition to the anti-inflammatory effects.